3-((2-(Pyridin-2-yl)-6-(4-(vinylsulfonyl)-1,4-diazepan-1-yl)pyrimidin-4-yl)amino)propanoic Acid

ID: ALA4294426

Chembl Id: CHEMBL4294426

PubChem CID: 137349487

Max Phase: Preclinical

Molecular Formula: C19H24N6O4S

Molecular Weight: 432.51

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C=CS(=O)(=O)N1CCCN(c2cc(NCCC(=O)O)nc(-c3ccccn3)n2)CC1

Standard InChI:  InChI=1S/C19H24N6O4S/c1-2-30(28,29)25-11-5-10-24(12-13-25)17-14-16(21-9-7-18(26)27)22-19(23-17)15-6-3-4-8-20-15/h2-4,6,8,14H,1,5,7,9-13H2,(H,26,27)(H,21,22,23)

Standard InChI Key:  CPNWZGJHUIZVEZ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4294426

    ---

Associated Targets(Human)

KDM6A Tchem Lysine-specific demethylase 6A (39 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDM5A Tchem Lysine-specific demethylase 5A (893 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDM4A Tchem Lysine-specific demethylase 4A (52245 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 432.51Molecular Weight (Monoisotopic): 432.1580AlogP: 1.41#Rotatable Bonds: 8
Polar Surface Area: 128.62Molecular Species: ACIDHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 2.80CX Basic pKa: 6.91CX LogP: -0.90CX LogD: -1.36
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.64Np Likeness Score: -1.88

References

1. Horton JR, Woodcock CB, Chen Q, Liu X, Zhang X, Shanks J, Rai G, Mott BT, Jansen DJ, Kales SC, Henderson MJ, Cyr M, Pohida K, Hu X, Shah P, Xu X, Jadhav A, Maloney DJ, Hall MD, Simeonov A, Fu H, Vertino PM, Cheng X..  (2018)  Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5A.,  61  (23): [PMID:30392349] [10.1021/acs.jmedchem.8b01219]

Source